7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors

Details for Australian Patent Application No. 2008324525 (hide)

Owner Merck Patent GmbH

Inventors Roche, Didier; Hallakou-Bozec, Sophie; Schultz, Melanie; Carniato, Denis

Agent Davies Collison Cave

Pub. Number AU-A-2008324525

PCT Pub. Number WO2009/059666

Priority 07291325.4 05.11.07 EP

Filing date 1 October 2008

Wipo publication date 14 May 2009

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/059666 Priority application(s): WO2009/059666

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008324535-Dishwasher with conductivity measurement

2008324508-Rack system and method of determining a climate condition thereof